# A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation

> **NCT04147416** · PHASE2 · COMPLETED · sponsor: **Sichuan Haisco Pharmaceutical Group Co., Ltd** · enrollment: 39 (actual)

## Conditions studied

- Sedation

## Interventions

- **DRUG:** HSK3486 0.1-0.2 /0.3 mg / kg group
- **DRUG:** Propofol 0.5-1.0/1.5 mg/kg group

## Key facts

- **NCT ID:** NCT04147416
- **Lead sponsor:** Sichuan Haisco Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-22
- **Primary completion:** 2020-05-31
- **Final completion:** 2020-07-03
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147416, "A Study Evaluating the Efficacy and Safety of HSK3486 for Sedation". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04147416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*